Isomorphic Labs in talks to raise $5bn at a $50bn valuation, Bloomberg reports
Isomorphic Labs, the drug discovery company spun out of Google DeepMind, is in talks to raise about $5bn, Bloomberg reported on Wednesday. The round would put the Isomorphic Labs valuation at about $50bn, according to people familiar with the matter.
Reported so far by one publisher.
Summary from The Next Web.
Reporting1
The Next Web Isomorphic Labs in talks to raise $5bn at a $50bn valuation, Bloomberg reports · Cristian Dina
Related
Topics Google GeminiGoogle